Fenofibrate D6
| Product Name | Fenofibrate D6 |
|---|---|
| Alternate Names | Fenofibrate Stable Isotopes, Stable Isotopes of Fenofibrate |
| CAT No. | CS-T-53056 |
| CAS No. | 1092484-56-4 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 366.87 g/mol |
| Mol. For. | C₂₀H₁₅D₆ClO₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Fenofibrate |
| Purity | 95% |
| Therapeutic | Anti-Hyperlipidemics |
| Smileys | CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl |
| Canonical Smiles | CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl |
| InchIKey | YMTINGFKWWXKFG-LIJFRPJRSA-N |
| Inchl | InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3/i3D3,4D3 |
| IUPAC | propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-3,3,3-trideuterio-2-(trideuteriomethyl)propanoate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Fenofibrate D6 is a deuterated analogue of the drug fenofibrate, which is used to treat high levels of cholesterol and triglycerides in the blood. Fenofibrate D6 is used in research studies to determine the pharmacokinetic and metabolic properties of fenofibrate.
The chemical formula of Fenofibrate D6 is C20H10D6ClO4, with a molecular weight of 373.89 g/mol. It is a white to off-white powder with a melting point of 80-82°C and is soluble in ethanol, methanol, and acetonitrile.
Fenofibrate D6 works by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha), which regulates the expression of genes involved in lipid metabolism. This leads to a decrease in the production of triglycerides and an increase in the production of high-density lipoprotein (HDL) cholesterol, the so-called "good" cholesterol.
In research studies, Fenofibrate D6 is typically administered orally in the form of capsules or tablets. The recommended dose varies depending on the study, but typically ranges from 100 to 200 mg per day.
In conclusion, Fenofibrate D6 is an important tool in research studies to understand the pharmacokinetic and metabolic properties of fenofibrate. It is an effective medication for the treatment of high levels of cholesterol and triglycerides in the blood, and its usage can lead to significant improvements in cardiovascular health.
Get an Instant Quote
Related Compounds
Dihydro Fenofibrate-d6 | Fenirofibrate-d6 Acyl-β-D-glucuronide (Mixture of Diastereomers) | Fenofibrate D7 | Fenofibrate 13C6 | Fenofibrate D4 |